Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAGLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC39A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPOAP1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NKRF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUFM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STAG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCFD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HYAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC643201 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LSM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on